Runge Jeffrey W. 4
4 · Aditx Therapeutics, Inc. · Filed Jun 2, 2021
Insider Transaction Report
Form 4
Runge Jeffrey W.
Director
Transactions
- Purchase
Common Stock
2021-06-01$2.94/sh+700$2,055→ 3,200 total - Purchase
Common Stock
2021-06-01$2.94/sh+3,000$8,820→ 12,500 total - Purchase
Common Stock
2021-06-01$2.94/sh+700$2,061→ 3,900 total - Purchase
Common Stock
2021-06-01$2.93/sh+1,600$4,688→ 5,500 total - Purchase
Common Stock
2021-06-01$2.93/sh+2,000$5,860→ 9,500 total - Purchase
Common Stock
2021-06-01$2.93/sh+2,000$5,860→ 7,500 total